UMC Utrecht Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT02349165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Iris Sommer | Julius Center, UMC Utrecht | MJM Bonten | Nienke Soeters | UMCU - Academica Hospital Utrecht | UMCU - Academic Hospital Utrecht

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 4)

Bacteremia (Phase 3)

Disease (Phase 3)

Hyperkinesis (Phase 4)

Mental Disorders (Phase 3)

Psychotic Disorders (Phase 3)

Respiratory Sounds (Phase 4)

Schizophrenia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 11